Abstract
Diabetes treatment should be effective and cost-effective. HbA1c-associated complications are costly. Would patient-centered care be more (cost-) effective if it was targeted to patients within specific HbA1c ranges?
| Original language | English |
|---|---|
| Pages (from-to) | 3054-61 |
| Number of pages | 8 |
| Journal | Diabetes Care |
| Volume | 36 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - Oct 2013 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver